(6260) Ingenia 3 0T R5
Total Payments
$2.3M
Transactions
210
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $826,434 | 96 | 4 |
| 2022 | $847,571 | 83 | 0 |
| 2021 | $28,000 | 2 | 0 |
| 2020 | $582,354 | 29 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 206 | 100.0% |
| Food and Beverage | $84.29 | 4 | 0.0% |
Payments by Type
Research
$2.3M
206 transactions
General
$84.29
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| WF-010536 / Evaluation of Image Quality of 3D Synthetic MRI in Children | Philips Electronics North America Corporation | $847,571 | 0 |
| IO Clinical Fellowship | Philips Electronics North America Corporation | $171,600 | 0 |
| Refinement and Assessment of New MRI Techniques | Philips Electronics North America Corporation | $109,800 | 0 |
| RP 1236 Amplified MR assessment of Normal Pressure Hydrocephalus | Philips Electronics North America Corporation | $102,000 | 0 |
| Microstructural MRI Using Temporal Diffusion Spectroscopy | Philips Electronics North America Corporation | $67,200 | 0 |
| TRUST and ASE for Global Blood Therapeutics Voxelotor Trial | Philips Electronics North America Corporation | $59,400 | 0 |
| RP 1236 Amplified MR Assessment of Normal Pressure Hydrocephalus | Philips Electronics North America Corporation | $56,400 | 0 |
| Intellispace Discovery Applications in Genitourinary Malignancies | Philips Electronics North America Corporation | $45,000 | 0 |
| Robust Cardiovascular MRI in Congenital Heart Disease | Philips Electronics North America Corporation | $39,000 | 0 |
| ECS Study | Philips Electronics North America Corporation | $28,000 | 0 |
| Clinical Applications of CMR Patch | Philips Electronics North America Corporation | $22,800 | 0 |
| Advanced MR Imaging in the Diagnosis of Alzheimer's Disease and related Neurodegenerative Dementia | Philips Electronics North America Corporation | $18,000 | 0 |
| Comparing Knee Cartilage T2 and T1 Derived from MAPSS and Fast R1 Dispersion | Philips Electronics North America Corporation | $18,000 | 0 |
| Study MRCAT Improvements and Diffusion Imaging for Tumor Guidance | Philips Electronics North America Corporation | $17,400 | 0 |
| Optimization of New MR Cardiac Imaging Techniques | Philips Electronics North America Corporation | $16,200 | 0 |
| Cardiac Perfusion | Philips Electronics North America Corporation | $15,600 | 0 |
| Improving Diagnosis of Multiple Sclerosis through Non-contrast MRI Techniques | Philips Electronics North America Corporation | $12,000 | 0 |
| T2* segEPI as a Biomarker for Inflammatory Demyelination | Philips Electronics North America Corporation | $9,000 | 0 |
| Clinical Applications of CMR patch | Philips Electronics North America Corporation | $7,200 | 0 |
| Development of Fast 4D flow MR for Congenital Heart Disease | Philips Electronics North America Corporation | $6,000 | 0 |
Top Doctors Receiving Payments for (6260) Ingenia 3 0T R5
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $2.3M
- Total Doctors 4
- Transactions 210
About (6260) Ingenia 3 0T R5
(6260) Ingenia 3 0T R5 is a device associated with $2.3M in payments to 4 healthcare providers, recorded across 210 transactions in the CMS Open Payments database. The primary manufacturer is Philips Electronics North America Corporation.
Payment data is available from 2020 to 2023. In 2023, $826,434 was paid across 96 transactions to 4 doctors.
The most common payment nature for (6260) Ingenia 3 0T R5 is "Unspecified" ($2.3M, 100.0% of total).
(6260) Ingenia 3 0T R5 is associated with 20 research studies, including "WF-010536 / Evaluation of Image Quality of 3D Synthetic MRI in Children" ($847,571).